Online HRT in Delaware: What’s Legal, What It Costs, and What to Verify First

Educational research, not medical advice. Not reviewed by a clinician. How we verify pricing and provider claims →

Some provider links below are affiliate links labeled “Sponsored.” If you use one, we may earn a commission at no extra cost to you. It doesn’t change our rankings — we tell you plainly where our highest-paying partner isn’t your best answer. Full disclosure →

Online HRT is legal and available in Delaware. A clinician can evaluate you by video — or, when the same standard of care can be met, through secure asynchronous care — and prescribe when it’s clinically appropriate, as long as they’re authorized to treat Delaware patients. Which provider fits you comes down mostly to how you pay.

Delaware law is unusually specific about what has to happen in that visit. Seven things, written into the statute.Most women have never been told what they are — and one of them is a document you’re entitled to receive that almost nobody thinks to ask for. We’ll give you all seven below.

The bottom line:Online hormone replacement therapy (HRT) — the estrogen, progesterone, and related medicines used to treat menopause symptoms — is legal in Delaware through a clinician licensed or registered to treat patients here. Midi Health is the strongest insurance-first option when your exact commercial plan is accepted. A low-cost cash visitwith a prescription filled at your own Delaware pharmacy is often cheaper if you’re paying yourself. Your symptoms, your insurance situation, and whether you want FDA-approved or compounded medication decide the rest.

This guide covers menopause and perimenopause hormone therapy for women located in the state of Delaware. It is not about gender-affirming hormone therapy, and it is not about Delaware, Ohio.

This page is for you if:you’re in Delaware, you have menopause or perimenopause symptoms, you’re tired of waiting, and you want to know which route actually works here before you pay anyone.

Online care may not be your first step if:you have unexplained vaginal bleeding, you might be pregnant, or you need an exam, imaging, or a biopsy. A history of breast or uterine cancer, blood clots, stroke, or liver disease needs individualized clinician review before systemic hormone therapy — that review can sometimes begin virtually, but it may require an in-person or specialist visit. We cover all of this in detail below.

Your fastest path, by what matters most to you

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

The right online HRT provider isn’t the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can’t resolve those for you, use The HRT Index’s Find My HRT Path tool to match your situation to the right provider and to flag when online care isn’t the right starting point, before your first consult.

Is online HRT legal in Delaware?

Yes. Delaware’s telehealth law lets a clinician establish care and prescribe hormone therapy remotely, by video or — when the provider can meet the same standard of care as an in-person visit — through asynchronous store-and-forward care. What Delaware requires is that seven specific things happen in that encounter. Prescribing based only on an internet questionnaire, with no proper clinical relationship behind it, is prohibited.

This is the first thing most women want to know, because the ads look like ads and virtual medicine can feel too easy. So let’s use Delaware’s own rulebook instead of anyone’s marketing.

Delaware’s telehealth chapter — Chapter 60 of Title 24 of the Delaware Code — spells out what a valid encounter must contain. It applies to health-care providers licensed by the professional boards listed in § 6002, including the Board of Medical Licensure and Discipline, the Board of Nursing, and the Board of Pharmacy. That breadth is unusual, and it works in your favor.

The seven things Delaware law requires in your visit

We turned the statute (24 Del. C. § 6003(a)) into a checklist you can actually use. This is the single most useful thing on this page. Screenshot it.

Number 7 is the sleeper. Delaware law says you get a written summary of your visit. Most people don’t know to expect one. Now you do — and if a service never sends it, you have a concrete reason to ask why.

Do you need blood tests before starting HRT?

Usually not, and this is where a lot of women get stuck waiting on labs they may not need.

Delaware law itself doesn’t set a menopause-specific testing rule — it requires the clinician to meet the applicable professional standard of care. That standard comes from the clinical bodies. ACOG says hormone testing generally isn’t recommended before starting hormone therapy for menopausal symptoms, because treatment decisions are usually guided by your symptoms, your menstrual changes, and your medical history. NICE guidance likewise supports diagnosing menopause on symptoms, not hormone levels, in women over 45.

So if an online clinician doesn’t order estrogen levels before treating you, that isn’t a red flag. It’s often standard practice. A clinician may still order testing if your picture is unclear, if you’re younger, or if another condition needs ruling out.

Does Delaware ban “questionnaire-only” prescribing?

Here’s the nuance nearly every competing page gets wrong. Delaware doesn’t ban online questionnaires. The statute (§ 6003(c)) says that “in the absence of a proper health-care provider-patient relationship,” a provider may not prescribe “solely in response to an internet questionnaire, an internet consult, or a telephone consult.” Separately, § 6003(b) expressly permits asynchronous, store-and-forward care to establish that relationship — but only if the provider determines the same standard of care as an in-person visit can be met, and the seven required elements actually happen.

So the real question isn’t “is asynchronous care legal in Delaware?” It is. The question is whether those seven elements actually happened. That’s something you can check yourself, which is the whole point of the list above.

If you live in Delaware but see a clinician across the state line

Delaware borders Pennsylvania, Maryland, and New Jersey, and plenty of us cross the line for care. But authority follows where you are sitting.Delaware defines the “originating site” as the place in Delaware where you’re located during the visit. Driving to a Pennsylvania office in person is fine. That same clinician video-calling you at your kitchen table in Newark needs Delaware authority. We’ll show you how to check that in two minutes.

Which online HRT providers actually serve Delaware?

Four telehealth options are realistically in play for a Delaware resident: Midi Health, Sesame, Hers, and Winona. They differ most on the thing that decides your cost — how you pay. Two bundle medication into a flat monthly fee. One bills commercial insurance and sends prescriptions to your pharmacy. One lets you choose a clinician and pay cash per visit.

We read each provider’s own current pricing, formulary, and availability pages to build this. Every figure is either published by that provider or traced to a dated source. Where something can only be confirmed at booking or checkout, we say so instead of guessing.

How to read the evidence labels: Verified= confirmed on the provider’s own current page. Confirm live = the honest answer depends on your plan, your address, or the clinician available today, so check it before you pay. Provider-stated = the company says it; we have not independently verified the finished product.

A consult never guarantees a prescription. Any clinician may recommend a different product, request records or testing, refer you for in-person care, or decline to prescribe — and a visit fee may still apply.

Two traps in provider marketing

Watch these. They’re what separate an informed buyer from a frustrated one.

The limitation you should know about our top pick

We’ll be straight with you, because it’s honest and because it’ll save you a wasted signup.

Midi’s biggest strength is that it bills insurance. In Delaware, that strength is narrower than it looks. Midi is in-network with most PPO plans — and on Delaware’s 2026 marketplace, Highmark is the carrier offering PPO products. Meanwhile Aetna, the carrier Midi lists first on its own Pennsylvania and Maryland pages, appeared among Delaware’s 2025 marketplace carriers but is not among the three offering 2026 coverage. Midi also doesn’t publish a Delaware page, so unlike its neighbors there’s no carrier list to check in advance. And Midi’s own site is clear that coverage varies by plan.

Here’s why that’s not a dealbreaker — and why it’s genuinely good news for the right person. Because Midi bills insurance instead of packing medication into a subscription, when your plan is accepted it’s usually the least expensive way to reach a menopause-focused clinician — and it sends commercially available, FDA-approved prescriptions to your own pharmacy, on your own drug benefit. That’s the structure most likely to stay affordable over years, not months.

If Midi doesn’t take your plan, don’t fight it. Skip to the cash-visit route below, where a low care fee plus a prescription filled at your own Delaware pharmacy usually beats a bundled subscription. You lose nothing but the insurance billing.

Which online HRT route fits your Delaware insurance?

Your plan type and your provider’s network agreement — not the provider’s advertising — decide whether insurance helps you here. Delaware’s 2026 individual marketplace has three carriers: Highmark Blue Cross Blue Shield (PPO products), AmeriHealth Caritas (HMO), and Ambetter by Celtic (EPO). If your medical benefit won’t cover a telehealth menopause visit, your pharmacy benefit is usually the lever that still works.

This is the section that saves you money. Ninety seconds, tops.

A quick note on 2026 pricing: approved rate increases for Delaware’s individual market ran roughly 25% for Highmark, 31.8% for Ambetter by Celtic, and 34.98% for AmeriHealth Caritas. Delaware’s Insurance Department says about eight in ten qualifying marketplace customers receive financial help.

What Delaware law already guarantees insured patients

Even before any new legislation takes effect, Delaware’s insurance code (18 Del. C. § 3370) gives you real protections on telehealth. Your plan can’t refuse to cover a service solelybecause it was delivered by telemedicine. It has to reimburse a covered telehealth service “on the same basis and at least at the rate” it pays for the same service in person. And it can’t apply a copay, coinsurance, deductible, or benefit limit to telehealth that it wouldn’t apply to comparable in-person care.

Know the boundaries too, so you’re not blindsided: parity doesn’t make an excluded service covered, doesn’t turn an out-of-network provider into an in-network one, and doesn’t override medical-necessity or benefit rules. These provisions also don’t override Medicare or Medicaid plan requirements, don’t apply to limited policies like accident-only coverage, and don’t bind self-funded employer plans.

What does online HRT actually cost in Delaware?

There are two cost structures, and mixing them up is the most common pricing mistake. Bundled plans charge one monthly fee that includes medication. Visit-based providers charge a care fee, and you buy medication separately. Compare your first 90 days — not a single “starting at” number.

We’ll show the math. These are calculated from published prices, not treatment quotes, and every medication scenario assumes the clinician actually prescribes that product.

Bundled plans (medication included)

Care fee + your own pharmacy (often the cheapest route)

Then you add the medication. Commonly listed cash prices on national discount programs run roughly $10–30/month for generic oral estradiol, $35–45/month for an estradiol patch, and $15/month for micronized progesterone. Those are national list prices, not a Delaware quote — check your own pharmacy and ZIP, and check your drug plan first, since it may beat them.

So the realistic math: a woman on oral estradiol plus progesterone lands around $25–45/month in medication. On a patch plus progesterone, closer to $50–60/month. Add your care fee on top. For many women that still comes in under a bundled subscription — and it runs on your own benefit, with a pharmacist you can walk in and talk to.

What’s not in these numbers: labs where they apply, shipping, what happens when an introductory rate ends, and cancellation terms. Ask before you enter a card.

How do you check that your prescriber can treat Delaware patients?

For the professions governed by Delaware’s telehealth chapter, a clinician’s authority comes from one of three places: a Delaware license, an applicable interstate compact pathway, or a Delaware interstate telehealth registration. All three show up in one free public lookup — and the registration route gives you a Delaware complaint channel against an out-of-state clinician.

You don’t have to take a website’s word for it. Two minutes, no cost.

Why the registration route has teeth

To hold a Delaware interstate telehealth registration, a clinician must be licensed and in good standing in everystate where they hold a license, must not be the subject of a pending administrative complaint, and must not be under investigation anywhere — continuously, not just at signup. Physicians and physician assistants, for example, must submit a National Practitioner Data Bank self-query, a federal report of malpractice and disciplinary history.

And by registering, the clinician consents to Delaware law, to the personal jurisdiction of Delaware’s courts, and to the Delaware board’s complaint, investigation, and hearing process — with discipline reportable nationally.

Translation: you have a Delaware complaint route against an out-of-state telehealth clinician. That’s real accountability, and it’s part of why a legitimate service will name your clinician before you pay.

Your two-minute check

1. Find the treating clinician’s full name on the provider’s site or in your intake confirmation.
2. Go to Delaware’s license verification tool: delpros.delaware.gov/OH_VerifyLicense
3. Search the name. Confirm the license or registration is active, and review any public disciplinary or limitation information shown.
4. If no clinician is named before checkout, ask support who will treat you — and get the answer in writing.
5. If something goes wrong later, the Division of Professional Regulation’s investigative unit accepts complaints.

Before you pay anyone, verify four things:the clinician’s Delaware authority, your exact plan or cash fee, the exact finished medication you’ll receive, and your first-90-day total plus the cancellation rule. Every one of those is answerable in a few minutes — and every one of them is a question a legitimate provider will answer directly.

What would Delaware’s menopause coverage bill change — and when?

Delaware lawmakers passed a menopause and perimenopause coverage bill in June 2026. As of July 23, 2026, Senate Substitute 1 for Senate Bill 319 had passed the General Assembly but was not shown as enacted in the official bill record — no chapter number, no effective date. Even if it becomes law, its own text says it would apply only to policies issued or renewed after December 31, 2027.

You may have seen headlines saying Delaware “passed menopause coverage.” That’s accurate as far as it goes. What almost nobody adds is the date — and the date is the whole story for anyone budgeting this year.

The bill is broadly bipartisan: it cleared the Senate 21–0 on June 17, 2026 and the House 36–1 on June 25, 2026, sponsored by Senator Nicole Poore and Representative Kamela Smith with 29 co-sponsors from both parties. Check the Delaware General Assembly’s bill record for its current status before assuming it’s law.

What it would require

For individual plans, group and blanket plans, the state employee health plan, and Delaware Medicaid, the bill would require coverage of:

• Consultation and diagnostic testing
• Hormonal therapies, including hormone replacement therapy and bioidentical hormone treatments, that are FDA-approved
• Non-hormonal treatments including SSRIs, SNRIs, and neurokinin B antagonists (a newer class of non-hormonal drugs for hot flashes)
• All FDA-approved drugs, devices, and combination products for menopause and perimenopause symptoms
• Therapy for menopause induced by hysterectomy
• Behavioral health care, pelvic floor physical therapy, bone health screening and medication, and preventive services including osteoporosis and cancer

It would also require insurers to give you clear, accessible information about what’s covered. And the most valuable provision: medically necessary hormone replacement therapy covered under the bill could not be denied or limited when supported by national clinical guidelines or peer-reviewed literature, and could not be subject to prior authorization or step therapy — subject to the bill’s stated exceptions, including applicable federal Medicaid law.

The bill even lists the symptoms it would cover: irregular periods, hot flashes, vaginal or bladder changes including genitourinary syndrome of menopause (GSM), decreased fertility, bone loss, elevated LDL cholesterol, and sleep disturbances including night sweats.

The two things nobody else is telling you

One: it wouldn’t help you in 2026 or 2027. Section 5 says the Act applies to policies “issued, renewed, modified, altered, amended, or reissued after December 31, 2027.” Your plan today isn’t bound by it. Anyone telling you Delaware coverage just improved is describing something that hasn’t started.

Two: it wouldn’t make an out-of-network cash telehealth company covered. The bill preserves a plan’s right to impose deductibles, coinsurance, allowable-charge limits, and “a provision restricting coverage to services by a licensed, certified, or carrier-approved provider or facility.” It does not override network restrictions. So even once it applies, a cash telehealth company outside your network stays outside your network.

Other limits worth knowing: it wouldn’t apply to accident-only, specified-disease, hospital indemnity, Medicare supplement, long-term care, or disability policies. Group plans would carry a religious-employer exclusion. The Medicaid provisions follow federal law.

Why the bill was rewritten to say “FDA-approved”

The Senate substitute’s own synopsis states that it changed the definition of hormone replacement therapy to clarify that it “must be approved by the United States Food and Drug Administration,” and that it “removes pellet medication from the definition… because it is not currently approved by the United States Food and Drug Administration for treating menopause or perimenopause.”

Be precise about what that means. It sets the scope of a proposed insurance mandate — it is nota prescribing ban. Compounded therapy and pellets remain lawful for a clinician to prescribe when otherwise appropriate. But for an insurance-sensitive Delaware page, it tells you exactly where covered care is heading: toward FDA-approved products. That’s why our recommendations lean that way, and why we’d rather you start there.

Does Delaware Medicaid cover HRT?

Delaware Medicaid can cover hormone therapy, but coverage depends on the exact drug, dosage form, Preferred Drug List status, diagnosis, and any authorization requirements. The route that works is a Medicaid-participating Delaware clinician — and one Delaware-specific quirk decides where your prescription actually gets paid.

Delaware runs Medicaid through the Diamond State Health Plan, with mandatory managed care for adults. The state lists AmeriHealth Caritas, Delaware First Health, and Highmark Health Options as its managed care organizations. Plan rosters change with state contracts — confirm yours with the Health Benefits Manager at 1-800-996-9969, and remember you can switch plans within 90 days of enrollment or during annual open enrollment.

Now the detail no competing page tells you. In Delaware Medicaid’s own words: “Prescription and non-emergency medical transportation services are covered directly by Medicaid, not through the MCO.”

That means your HRT prescription runs through Delaware’s state-administered Medicaid pharmacy benefit and the Delaware Preferred Drug List — not your managed care organization’s formulary. Practical translation: if an office tells you “your plan won’t cover that,” the right question is about the state drug list, not your MCO. Your Medicaid card goes to the pharmacy. If a medication isn’t preferred, ask about the exception and prior-authorization process.

One honest note on the platforms above: Midi states it cannot treat Medicaid patients even as self-pay. The others don’t bill insurance at all, so a Medicaid enrollee using them would be paying cash for care she may be able to get covered. Check a Medicaid-participating clinician and the state pharmacy benefit before you pay for any subscription.

What does Medicare cover for HRT in Delaware?

If you’re on Medicare, a Medicare-participating clinician can bill your visit under Part B or Medicare Advantage, and your medication cost depends on your Part D or Medicare Advantage drug coverage. At least one telehealth menopause clinic accepts Medicare beneficiaries only as self-pay patients who cannot submit any claim.

Midi is specific about this: it isn’t covered by Medicare or any Medicare-related plan. It can see Medicare beneficiaries as self-pay, but you cannot submit claims related to Midi visits, medications, or associated services.

So for most Medicare-eligible women, the practical route is a participating local clinician plus your drug plan. It isn’t the flashiest option, but it uses the coverage you already pay for.

What help is available if you’re uninsured or have a high deductible?

Before you buy any monthly subscription, check Delaware hospital financial assistance. Governor Meyer signed Delaware’s hospital financial-assistance law on July 20, 2026. Its minimum assistance standards begin January 1, 2027, with the remaining provisions beginning when final implementing regulations are noticed or July 1, 2027, whichever comes first. Hospitals have financial assistance policies right now — ask about those today.

This is one of the strongest statewide standards in the country. Here’s what the new minimums will require once they take effect:

For scale, using the 2026 HHS poverty guidelines, 300% is $47,880 for one person and $81,960 for a household of three. Those are illustrations — use the guideline in effect when you receive care. The law will also require automatic screening for financial assistance and bar aggressive collection actions while an application is pending. The Governor’s office describes it as the highest statewide free-care threshold in the country.

If you’re shopping coverage instead: Delaware’s open enrollment for 2026 coverage closed January 15, 2026. Outside open enrollment you generally need a qualifying life event for a Special Enrollment Period — a move, a job change, a marriage, a birth, or losing other coverage. If one of those has happened to you, you may be able to enroll now.

Should you choose FDA-approved or compounded HRT?

These are different regulatory categories, not two versions of the same thing. FDA-approved products are reviewed for safety, effectiveness, and manufacturing quality. Compounded preparations are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before they are marketed. ACOG recommends FDA-approved menopausal hormone therapies as the default when an approved formulation meets the patient’s needs.

This is where marketing gets slippery, so let’s be plain.

“Bioidentical”is commonly used to describe a hormone that’s chemically identical to one your body makes. The term says nothing about FDA approval, safety, effectiveness, or manufacturing quality. Many FDA-approved products — standard estradiol patches, gels, and micronized progesterone capsules — arebioidentical. So “bioidentical” alone is not a reason to choose a compounded product over an approved one.

“Compounded”means a pharmacy mixes the medication to order. It can be appropriate for a specific need an approved product can’t meet — an allergy to an inactive ingredient, or a dose or form that isn’t commercially available. But the finished compounded product is not FDA-approved. And a compounded product should never be described as safer, more natural, or clinically proven compared with an approved one — there’s no FDA review standing behind those claims.

One more thing to know: 503A compounding pharmacies are principally overseen by state boards and operate under federal statutory conditions. A “503A” or “503B” label describes the pharmacy category. It does not make the finished drug FDA-approved.

Where our four options actually stand

And a phrase to be skeptical of wherever you see it: “FDA-approved ingredients” is not evidence that the finished product is FDA-approved, equivalent to an approved drug, or manufactured to the same standard.

How to verify a product yourself

Check Drugs@FDA or the Orange Book(both free at fda.gov) by the product’s name, strength, dosage form, and manufacturer. One trap: an NDC number (the code on a drug package) does notprove FDA approval — use it only to confirm you’re looking at the same product being dispensed.

About the 2026 warning-label news

You may have heard the boxed warnings on menopause hormone therapy changed. The accurate version: the FDA requested labeling updates in November 2025 and approved changes for a first batch of six products in February 2026. Some warnings came out of the box — but systemic estrogen-alone still carries a boxed warning about endometrial cancer, and cardiovascular and breast cancer information remains in the labeling. The FDA did not declare HRT safe for everyone. Your history still matters, and it deserves an actual conversation rather than a headline.

Our incentive, stated plainly

You deserve to know this: Winona is our highest-paying partner, and it does serve Delaware. We’re still not making it the default answer on this page. ACOG recommends FDA-approved menopausal hormone therapies when an approved formulation meets the need, and Delaware’s own legislature just wrote FDA-approved into its coverage bill. We follow that. Winona stays in our comparison, labeled accurately, for the woman who wants a compounded option, fits the 35–59 age range, and understands exactly what she’s choosing.

Do your symptoms point to systemic or local therapy?

Hot flashes and night sweats raise a different treatment question than vaginal dryness or urinary symptoms. Systemic therapy — patch, pill, gel, or spray — treats the whole body. Low-dose vaginal estrogen generally produces much lower systemic exposure and targets local symptoms. Many women use one; some use both.

Getting this right before your consult is worth more than any provider comparison, because it changes what you should ask for.

Systemic symptoms— hot flashes, night sweats, and the sleep disruption they cause — usually point toward systemic estrogen:

Local symptoms— vaginal dryness, painful sex, and some urinary symptoms (GSM) — often respond to low-dose vaginal estrogen, which keeps most of the hormone where it’s needed. Important: vaginal estrogen isn’t a weaker version of systemic therapy. It does a different job, and it won’t resolve hot flashes on its own. If a plan offers you a vaginal cream, know that it’s local treatment — not a substitute for a systemic patch or pill.

If you still have a uterus:systemic estrogen usually needs to be paired with a progestogen to protect the uterine lining. That’s a clinician’s decision based on your dose, route, and history — not a checkout option you pick yourself.

Can women get testosterone online in Delaware?

There is no FDA-approved testosterone product for menopausal symptoms in women. A clinician may prescribe an FDA-approved product marketed for men off-label, or a compounded testosterone product that is not FDA-approved. Testosterone is a Schedule III controlled substance and requires a prescription from a clinician holding the registrations required for controlled-substance prescribing.

Set expectations before you go looking. Of the options on this page, Sesame states its online providers do not prescribe controlled substances, and Winona states it does not prescribe testosterone. So neither is your route here.

Federal telemedicine flexibilities for controlled-substance prescribing remain extended through December 31, 2026, subject to federal and Delaware law — which means rules in this area can and do change. If testosterone is your main goal, work with a Delaware clinician who handles it, and expect a real evaluation rather than a quick add-on.

When is online HRT not the right starting point?

Some situations need in-person evaluation, and a good online service will say so rather than sell to you. Unexplained bleeding, possible pregnancy, and anything requiring an exam, imaging, or a biopsy come first. A history of hormone-sensitive cancer, clots, stroke, or liver disease needs individualized clinician review before systemic hormone therapy — that review can sometimes begin virtually, but it may require a specialist.

We’d rather lose the click than route you wrong. Here’s the honest triage.

Get evaluated before starting systemic hormone therapy if:

• You have unexplained or postmenopausal bleeding. This needs prompt evaluation. Both harmless and serious causes are possible, and it should be worked up before systemic estrogen.
• You have a personal history of breast or endometrial cancer, stroke, heart attack, blood clots, or liver disease. ACOG describes systemic hormone therapy as usually not recommended with these histories. That’s a treatment question requiring individualized review — often with an oncologist or menopause specialist — not automatically a reason telehealth can’t begin the conversation.
• You have migraine with aura, uncontrolled blood pressure, or a complex cardiovascular history. These need individualized evaluation and reliable clinical measurements. Not a form.
• You might be pregnant, or you need an exam, ultrasound, or biopsy.

This isn’t a complete list of situations needing in-person care.

A trustworthy provider facing any of these should explain why, point you to the right level of care, and be clear about its refund policy. “Not yet” can be the responsible answer — and honestly, a service willing to say it is the kind you want.

Where can you get in-person menopause care in Delaware?

Delaware is geographically small, but that doesn’t make access easy — the bottleneck is wait time and the number of clinicians who focus on menopause, especially in Sussex County. All three counties have OB/GYN practices, and The Menopause Society’s finder lets you search certified practitioners by ZIP.

If online isn’t your fit, or you’d simply rather be seen, start here. Verified from each organization’s own site in July 2026.

About southern Delaware:if you’re down there, you already know appointments can take a while. A 2026 health-system report on Sussex County described a growing older population, a shortage of primary care providers, limited specialist access, and areas designated medically underserved — with ChristianaCare announcing plans for a new southern campus. That access gap is a real reason virtual care exists. But for the situations in the section above, the wait is worth it.

One piece of context that explains a lot of dismissive appointments: in a published survey of U.S. OB-GYN residents, only about 20.8%reported a formal menopause medicine curriculum in their training. That reported gap may help explain why menopause expertise varies so much from one office to the next. If you’ve felt brushed off, you’re allowed to ask for a clinician who focuses on this. That’s not being difficult. That’s being a good patient.

Getting your records where they belong:Delaware law requires use of the Delaware Health Information Network in telehealth practice when the applicable professional board requires it. An out-of-state cash platform likely isn’t connected to it — so if you use one, ask whether they’ll send your written visit summary to your Delaware clinician. Continuity matters more than people expect.

How did The HRT Index verify this Delaware guide?

This page is editorial research. It is not medical advice, and it is not reviewed by a clinician. Here’s exactly what we checked and where, so you can check it yourself.

Verified in July 2026 from primary sources: Delaware’s telehealth chapter (24 Del. C. Ch. 60) and telehealth insurance provisions (18 Del. C. § 3370) at delcode.delaware.gov; the full text and current status of Senate Substitute 1 for Senate Bill 319 and Delaware’s hospital financial-assistance legislation at legis.delaware.gov, plus the Governor’s July 20, 2026 signing announcement; the Delaware Division of Professional Regulation’s interstate telehealth registration requirements; the Delaware Diamond State Health Plan program page; Delaware Insurance Department 2026 rate and marketplace information; and each provider’s own published pricing, formulary, availability, and cancellation pages.

What we could not confirm, and labeled as such: whether a Delaware-authorized menopause clinician is bookable on any given day; whether Hers’ menopause program reaches your specific Delaware address; the exact finished product and manufacturer any provider will dispense to you; and the Delaware Medicaid managed care roster, which changes with state contracts.

How we’re paid:links labeled “Sponsored” earn us a commission at no cost to you. It doesn’t change the order of this page — we tell you plainly where our highest-paying partner isn’t your best answer, and two of the strongest recommendations here earn us nothing at all.

Our method follows The HRT Index Verification Standard: we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check top providers monthly and the full roster quarterly. We evaluate on five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not publish numeric provider scores.

What do users say about these services?

Reviews tell you about the experience— speed, ease, whether someone listened. They can’t tell you a treatment is safe or effective for you, and we won’t use them that way.

Winona holds a strong service rating on Trustpilot: approximately 4.6 out of 5 from about 7,642 reviews, with roughly 83% rated five stars(captured July 2026). That’s aggregate service sentiment, not a medical outcome, and it reflects the experience of using the service rather than the appropriateness of any treatment.

Midi publishes patient comments on its own site that cluster around two themes: getting an appointment quickly, and having insurance accepted. Those are provider-collected comments, not independent research, and not evidence of a typical medical result.

We’re deliberately not quoting a hand-picked patient as proof of anything. If speed and simplicity matter most to you, the cash and bundled routes are built for that. If using insurance matters most, that’s Midi’s lane. Choose on fit, not on someone else’s story.

Frequently asked questions about online HRT in Delaware